| abstract |
Cytoprotective compounds, many of which are benzofuran derivatives, are certain ischemic or inflammatory conditions including but not limited to stroke, myocardial infarction, congestive heart failure, and skin disorders characterized by inflammation or oxidative disorders Useful for the treatment of They are also useful in the manufacture of pharmaceutical and cosmetic formulations for the treatment of such conditions. The invention also relates to a method of treating inflammation by reducing C-reactive protein (CRP). The invention also relates to cosmetic formulations for the treatment of skin inflammation and other skin disorders. |